69238-1702 : Deferasirox 90 mg Oral Granule


NDC: 69238-1702
Labeler: Amneal Pharmaceuticals Ny LLC
Product Type: Human Prescription Drug
Drug Name:  Deferasirox
Dosage Form: Oral Granule
Application #: ANDA214194
Rev. Date: 


NDC Package Codes:

  • 69238-1702-1: 1 GRANULE IN 1 PACKET (69238‑1702‑1)
  • 69238-1702-3: 30 GRANULE IN 1 CARTON (69238‑1702‑3)

Active Ingredients:

  • Deferasirox

Dosage Strength:

  • 90 mg

Pharmaceutical Classes:

  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]

Related Products:

Based on records with the same trade name.
  • 69238-1486 Deferasirox 90 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
  • 69238-1487 Deferasirox 180 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
  • 69238-1488 Deferasirox 360 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
  • 69238-1703 Deferasirox 180 mg Oral Granule by Amneal Pharmaceuticals Ny LLC
  • 69238-1704 Deferasirox 360 mg Oral Granule by Amneal Pharmaceuticals Ny LLC
  • 0093-3515 Deferasirox 360 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-3516 Deferasirox 180 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0093-3517 Deferasirox 90 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0591-3853 Deferasirox 180 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 0591-4730 Deferasirox 90 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4735 Deferasirox 180 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4740 Deferasirox 360 mg Oral Granule by Actavis Pharma, Inc.
  • 16714-993 Deferasirox 90 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-994 Deferasirox 180 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-995 Deferasirox 360 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 31722-011 Deferasirox 90 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-012 Deferasirox 180 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-013 Deferasirox 360 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-029 Deferasirox 90 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • 31722-030 Deferasirox 180 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69238-1702 QR Code

< Prev: 69238-1690Next: 69238-1703 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.